LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity

被引:113
|
作者
Fabisiak, Adam [1 ,2 ]
Murawska, Natalia [1 ,2 ]
Fichna, Jakub [1 ]
机构
[1] Med Univ Lodz, Dept Biochem, Fac Med, Lodz, Poland
[2] Med Univ Lodz, Dept Pathol, Fac Med, Lodz, Poland
关键词
Cathelicidin; LL-37; Antimicrobial peptide; OBSTRUCTIVE PULMONARY-DISEASE; NEUTROPHIL EXTRACELLULAR TRAPS; INFLAMMATORY BOWEL DISEASES; CONTROLLED CLINICAL-TRIAL; ALPHA-HELICAL PEPTIDES; AIRWAY SURFACE FLUID; ATOPIC-DERMATITIS; HUMAN MACROPHAGES; CYSTIC-FIBROSIS; IN-VIVO;
D O I
10.1016/j.pharep.2016.03.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antimicrobial peptides (AMPs) is a large family of compounds serving as natural antibiotics, widely distributed across the organism, mainly in mucus layers. They are designed to prevent pathogens from colonization. Among them, defensins and cathelicidins could be found. LL-37, the sole human cathelicidin draws particular attention because of its outstanding abilities. In addition to being a broad spectrum antibiotic, LL-37 has potent chemotactic and immunomodulatory properties. In this review, we discussed the potency of LL-37 as a therapeutic agent in four systems: immunological, respiratory, gastrointestinal and in the skin. We analyzed the main molecular pathways dependent on human cathelicidin and related them to specific diseases. We conclude that LL-37 shows a great potential to be further investigated and developed as a drug with clinical use. (C) 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.
引用
收藏
页码:802 / 808
页数:7
相关论文
共 50 条
  • [1] LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity
    Adam Fabisiak
    Natalia Murawska
    Jakub Fichna
    Pharmacological Reports, 2016, 68 : 802 - 808
  • [2] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Bucki, Robert
    Leszczynska, Katarzyna
    Namiot, Andrzej
    Sokolowski, Wojciech
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (01) : 15 - 25
  • [3] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Robert Bucki
    Katarzyna Leszczyńska
    Andrzej Namiot
    Wojciech Sokołowski
    Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 : 15 - 25
  • [4] Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide
    Golec, Marcin
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2007, 14 (01) : 1 - 4
  • [5] Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
    Reinholz, Markus
    Ruzicka, Thomas
    Schauber, Juergen
    ANNALS OF DERMATOLOGY, 2012, 24 (02) : 126 - 135
  • [6] ANTIMICROBIAL PEPTIDE CATHELICIDIN (LL-37) CONCENTRATION IN ACTIVE PULMONARY TUBERCULOSIS PATIENTS
    Sovira, N.
    Sutoyo, D. K.
    Burhan, E.
    Dillon, D. H.
    RESPIROLOGY, 2012, 17 : 133 - 133
  • [7] The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
    Kuroda, Kengo
    Okumura, Kazuhiko
    Isogai, Hiroshi
    Isogai, Emiko
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [8] Cathelicidin LL-37 (an antimicrobial peptide)-induced colistin dependence in Acinetobacter baumannii
    Lee, Ji-Young
    Hong, Yoon-Kyoung
    Ko, Kwan Soo
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 96 (04)
  • [9] The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
    Ibrahim H. Babikir
    Elsir A. Abugroun
    Naser Eldin Bilal
    Abdullah Ali Alghasham
    Elmuataz Elmansi Abdalla
    Ishag Adam
    BMC Infectious Diseases, 18
  • [10] The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
    Babikir, Ibrahim H.
    Abugroun, Elsir A.
    Bilal, Naser Eldin
    Alghasham, Abdullah Ali
    Abdalla, Elmuataz Elmansi
    Adam, Ishag
    BMC INFECTIOUS DISEASES, 2018, 18